RECURRENT HENOCH-SCHONLEIN PURPURA IN FAMILIAL MEDITERRANEAN FEVER

Familial Mediterranean fever (FMF) is a relatively rare disorder, characterized by recurrent self-limited attacks of fever and polyserositis. Diagnosis is made by clinical features, gene identification on chromosome 16 and clinical response to specific treatment. Different types of vasculitis have been reported in FMF. Henoch-Schonlein purpura (HSP) is one of them, usually with a benign clinical course. Repeated attacks of HSP have been rarely reported in FMF. This is the report of a 7-year-old girl who presented initially with recurrent fever and abdominal pain. After the primary diagnosis of FMF and appropriate treatment, she experienced two documented repeated attacks of HSP with severe renal involvement (crescentric glomerulonephritis) and protracted abdominal pain in the second one. Glomerulonephritis was controlled by methyl-prednisolone pulse therapy plus oral corticosteroid and azathioprine, but abdominal pain was resistant to steroids and revealed completely by intravenous immunoglobuline (IVIg) administration. In conclusion, it is suggested to consider the recurrence of HSP in cases with FMF to prevent irreversible renal complications. IVIg seems to be a good choice for the management of intractable abdominal pain of HSP.

[1]  F. Nicolás-Sánchez,et al.  [Familial Mediterranean fever]. , 2010, Medicina clinica.

[2]  F. Saulsbury.  Henoch–Schönlein purpura , 2001, Current opinion in rheumatology.

[3]  A. Duppenthaler.  [Recurrent febrile episodes--normal, periodic fever syndrome or immunodeficiency?]. , 2006, Therapeutische Umschau. Revue therapeutique.

[4]  S. Sengul,et al.  Two sisters with familial Mediterranean fever: lack of correlation between genotype and phenotype? , 2006, Journal of nephrology.

[5]  P. Aries,et al.  Intravenous immunoglobulin therapy in vasculitis , 2005, Clinical reviews in allergy & immunology.

[6]  E. Chouery,et al.  Familial Mediterranean fever (FMF) in Lebanon and Jordan: a population genetics study and report of three novel mutations. , 2005, European journal of medical genetics.

[7]  F. Saulsbury,et al.  Henoch‐Schönlein Purpura in a Child with Hyperimmunoglobulinemia D and Periodic Fever Syndrome , 2005, Pediatric dermatology.

[8]  D. Cattan.  MEFV mutation carriers and diseases other than familial Mediterranean fever: proved and non-proved associations; putative biological advantage. , 2005, Current drug targets. Inflammation and allergy.

[9]  A. Bakkaloğlu,et al.  Familial Mediterranean Fever (FMF) in Turkey: Results of a Nationwide Multicenter Study , 2005, Medicine.

[10]  Y. Shoenfeld,et al.  Intravenous immunoglobulin and the kidney--a two-edged sword. , 2004, Seminars in arthritis and rheumatism.

[11]  B. Kandemir,et al.  Familial Mediterranean fever and glomerulonephritis and review of the literature , 2004, Rheumatology International.

[12]  R. Gershoni-baruch,et al.  Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. , 2003, The Journal of pediatrics.

[13]  P. Fisher,et al.  Familial Mediterranean fever, Inflammation and Nephrotic Syndrome: Fibrillary Glomerulopathy and the M680I Missense Mutation , 2003, BMC nephrology.

[14]  A. Bakkaloğlu.  Familial Mediterranean fever , 2003, Pediatric Nephrology.

[15]  M. Tekin,et al.  Clinical, laboratory and molecular characteristics of children with Familial Mediterranean Fever‐associated vasculitis , 2000, Acta paediatrica.

[16]  M. Tekin,et al.  Familial Mediterranean fever--renal involvement by diseases other than amyloid. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  T. Martin,et al.  [Rheumatoid purpura and intravenous immunoglobulins]. , 1997, La Revue de medecine interne.

[18]  T. Martin,et al.  Purpura rhumatoïde et immunoglobulines intraveineuses , 1996 .

[19]  T. Shaw-Stiffel,et al.  Henoch-Schönlein purpura. , 1995, Postgraduate medicine.

[20]  S. Adnot,et al.  Immunomodulation with low-dose immunoglobulins for moderate IgA nephropathy and Henoch-Schönlein purpura. Preliminary results of a prospective uncontrolled trial. , 1995, Nephron.

[21]  H. Majeed,et al.  The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis). A six-year study. , 1990, The Quarterly journal of medicine.

[22]  F. Fernández-Nogués,et al.  [Familial, mediterranean fever]. , 1977, Revista clinica espanola.